|Bid||36.73 x 2900|
|Ask||36.94 x 1100|
|Day's range||36.44 - 37.25|
|52-week range||33.88 - 64.50|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||43.50|
|Forward dividend & yield||1.87 (5.03%)|
|Ex-dividend date||18 Aug 2020|
|1y target est||N/A|
To further aid employers with creating a safe and protected work environment, Walgreens has launched Walgreens Test & Protect™, a new program to aid businesses in their COVID-19 work plans and strategies. The program is part of Walgreens’ latest expansion of COVID-19 testing, which also includes increased capacity across its testing sites to allow for more than 500,000 COVID-19 tests per month.
Walgreens Boots Alliance (Nasdaq: WBA) today released the company’s first global diversity and inclusion (D&I) report, while also announcing recent efforts aimed at addressing healthcare disparity in underserved communities.
Walgreens today announced new offerings to support people with chronic and acute pain, including the launch of Walgreens brand diclofenac gel, an over-the-counter original prescription-strength arthritis pain relief in topical form. In addition, patients can receive free one-on-one consultations with Walgreens pharmacists who received specialized training in providing empathetic care and personalized pain management solutions.